The Global Vaccine Alliance, GAVI, a lead partner in the WHO-led COVAX initiative for COVID-19 vaccines has said the portfolio will continue rolling out the AstraZeneca vaccine despite a study
The Global Vaccine Alliance, GAVI, a lead partner in the WHO-led COVAX initiative for COVID-19 vaccines has said the portfolio will continue rolling out the AstraZeneca vaccine despite a study